Wu, Ke
Liu, Gang
Liang, Xinyu
Zeng, Jinsheng
Gong, Gaolang
Funding for this research was provided by:
National Natural Science Foundation of China (82021004, 82271300, 82471258)
National Natural Science Foundation of China (T2325006, 82172016)
Natural Science Foundation of Guangdong Province (2023A1515012739)
Fundamental Research Funds for the Central Universities (2233200020)
Science and Technology Program of Guangzhou (2023B03J0466)
Guangdong Provincial Clinical Research Center for Neurological Diseases (2020B1111170002)
Guangdong Province International Cooperation Base for Early Intervention and Functional Rehabilitation of Neurological Diseases (2020A0505020004)
Guangzhou Major Difficult and Rare Diseases Project (2024MDRD02)
Guangdong Provincial Engineering Center for Major Neurological Disease Treatment
Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease
Guangzhou Clinical Research and Translational Center for Major Neurological Diseases
Article History
Received: 24 October 2025
Accepted: 10 March 2026
First Online: 19 March 2026
Declarations
:
: The discovery cohort was approved by the Clinical Research Review Board of the First Affiliated Hospital of Sun Yat-sen University ([2012]283). The replication cohort was approved by the Washington University School of Medicine (WUSM) Internal Review Board. Written informed consent was obtained from each participant or a legal proxy.
: Not applicable.
: The authors declare no competing interests.